Verastem Revenue and Competitors
Estimated Revenue & Valuation
- Verastem's estimated annual revenue is currently $17.1M per year.
- Verastem's estimated revenue per employee is $155,000
Employee Data
- Verastem has 110 Employees.
- Verastem grew their employee count by 26% last year.
Verastem Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Verastem?
Verastem Oncology (Nasdaq: VSTM) is a biopharmaceutical company focused on developing medicines to improve survival and quality of life of cancer patients. Our portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth. Our people are inspired by the strength, tenacity and courage of those battling cancer. Verastem team is anchored by core values of character, urgency, respect, and excellence. We pride ourselves in being an organization committed to diversity and inclusion in order to achieve and sustain excellence. We believe that empowering employees is what makes them truly care about the important work they do. To join our team or for more information, please visit www.verastem.com. Twitter: @VerastemOncolog
keywords:N/A
N/A
Total Funding
110
Number of Employees
$17.1M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Verastem's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Head Communications and Patient Advocacy | Reveal Email/Phone |
3 | VP, Finance | Reveal Email/Phone |
4 | Senior Manager, Quality Operations | Reveal Email/Phone |
5 | Associate Director, Financial Planning and Analysis | Reveal Email/Phone |
6 | Head Safety and Pharmacovigilance | Reveal Email/Phone |
7 | Associate Director, Regulatory Affairs, CMC | Reveal Email/Phone |
8 | SVP- Corporate Development and External Engagement | Reveal Email/Phone |
9 | SVP, Technical Operations | Reveal Email/Phone |
10 | SVP Regulatory Affairs | Reveal Email/Phone |
Verastem News
4/14/2022 Verastem is now covered by analysts at Royal Bank of Canada. They set an outperform rating and a $5.00 price target on the stock.
Verastem secured up to $150M in non-dilutive funding from Oxford Finance. Now, the company expects their cash runway to last through 2025. The...
Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and...
Other Companies in Needham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $29.7M | 110 | 5% | $10M |
#2 | $15.8M | 113 | -4% | $49.5M |
#3 | $18.6M | 120 | 3% | N/A |
#4 | $30.3M | 121 | 2% | N/A |
#5 | $32.1M | 128 | 13% | $87.5M |